Lanrong Sun, Jiaying Lao, Haihui Guo, Jinzhong Xu, Yu-Hsin Chen, Xingguang Luo, Shencong He, Weiming Hu, Fan Wang, Li Chen, Yanlong Liu, Qizeng Wang, Wenhui Lin
{"title":"Association Between Soy Product Intake and Insomnia in Chinese Middle-Aged and Older Adults: A Cross-Sectional Study.","authors":"Lanrong Sun, Jiaying Lao, Haihui Guo, Jinzhong Xu, Yu-Hsin Chen, Xingguang Luo, Shencong He, Weiming Hu, Fan Wang, Li Chen, Yanlong Liu, Qizeng Wang, Wenhui Lin","doi":"10.2147/NSS.S506431","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objective: </strong>Insomnia has various adverse effects on middle-aged and older adults. Improving insomnia by adjusting diet has attracted attention. This study investigated the relationship between soy product intake and insomnia in middle-aged and older adults and explored the role of inflammatory factors.</p><p><strong>Methods: </strong>The study included 877 middle-aged and older adults aged ≥45 years which from general patients who made an appointment or were admitted to the cardiology department at Wenling Hospital in Taizhou City. The proportion of female participants is 35.01%. Soy product intake was assessed using the Food Frequency Questionnaire (FFQ), sleep was quantified using the Insomnia Severity Index (ISI). The median (IQR) of soy product intake is ≤1 time per week (≤1 time per week, 2-6 times per week) and the mean/SD value of insomnia score is 5.43/5.13.</p><p><strong>Results: </strong>In Chinese middle-aged and older adults, soy product intake was negatively correlated with insomnia (|r|s ≥ 0.117, ps < 0.001), C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α) and triglyceride (TG) levels (adjusted β: -0.139, 95% CI: -0.265 to -0.012; β: -0.049, 95% CI: -0.091 to -0.006; β: -0.043, 95% CI: -0.085 to -0, respectively). There was no significant correlation between soy product intake and White Blood Cell (WBC), Absolute Neutrophil Count (GRAM), Platelet Count (PLT), Interleukin-1β (IL-1β), Interleukin-2 (IL-2), Interleukin-6 (IL-6), Hemoglobin (Hb), Red Blood Cell (RBC), Low-Density Lipoprotein Cholesterol (LDL-C), High-Density Lipoprotein Cholesterol (HDL-C) and Total Cholesterol (TC) levels.</p><p><strong>Conclusion: </strong>Lower levels of soy product intake are associated with higher rates of insomnia in the middle-aged and older adults. Additionally, soy product intake is negatively correlated with peripheral blood CRP, TNF-α and TG levels. This study provides a new clinical perspective for middle-aged and older adults to enhance sleep through a balanced diet, wherein the inflammation and lipid may play a potentially crucial role.</p>","PeriodicalId":18896,"journal":{"name":"Nature and Science of Sleep","volume":"17 ","pages":"1837-1849"},"PeriodicalIF":3.4000,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12358130/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature and Science of Sleep","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/NSS.S506431","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objective: Insomnia has various adverse effects on middle-aged and older adults. Improving insomnia by adjusting diet has attracted attention. This study investigated the relationship between soy product intake and insomnia in middle-aged and older adults and explored the role of inflammatory factors.
Methods: The study included 877 middle-aged and older adults aged ≥45 years which from general patients who made an appointment or were admitted to the cardiology department at Wenling Hospital in Taizhou City. The proportion of female participants is 35.01%. Soy product intake was assessed using the Food Frequency Questionnaire (FFQ), sleep was quantified using the Insomnia Severity Index (ISI). The median (IQR) of soy product intake is ≤1 time per week (≤1 time per week, 2-6 times per week) and the mean/SD value of insomnia score is 5.43/5.13.
Results: In Chinese middle-aged and older adults, soy product intake was negatively correlated with insomnia (|r|s ≥ 0.117, ps < 0.001), C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α) and triglyceride (TG) levels (adjusted β: -0.139, 95% CI: -0.265 to -0.012; β: -0.049, 95% CI: -0.091 to -0.006; β: -0.043, 95% CI: -0.085 to -0, respectively). There was no significant correlation between soy product intake and White Blood Cell (WBC), Absolute Neutrophil Count (GRAM), Platelet Count (PLT), Interleukin-1β (IL-1β), Interleukin-2 (IL-2), Interleukin-6 (IL-6), Hemoglobin (Hb), Red Blood Cell (RBC), Low-Density Lipoprotein Cholesterol (LDL-C), High-Density Lipoprotein Cholesterol (HDL-C) and Total Cholesterol (TC) levels.
Conclusion: Lower levels of soy product intake are associated with higher rates of insomnia in the middle-aged and older adults. Additionally, soy product intake is negatively correlated with peripheral blood CRP, TNF-α and TG levels. This study provides a new clinical perspective for middle-aged and older adults to enhance sleep through a balanced diet, wherein the inflammation and lipid may play a potentially crucial role.
期刊介绍:
Nature and Science of Sleep is an international, peer-reviewed, open access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.
Specific topics covered in the journal include:
The functions of sleep in humans and other animals
Physiological and neurophysiological changes with sleep
The genetics of sleep and sleep differences
The neurotransmitters, receptors and pathways involved in controlling both sleep and wakefulness
Behavioral and pharmacological interventions aimed at improving sleep, and improving wakefulness
Sleep changes with development and with age
Sleep and reproduction (e.g., changes across the menstrual cycle, with pregnancy and menopause)
The science and nature of dreams
Sleep disorders
Impact of sleep and sleep disorders on health, daytime function and quality of life
Sleep problems secondary to clinical disorders
Interaction of society with sleep (e.g., consequences of shift work, occupational health, public health)
The microbiome and sleep
Chronotherapy
Impact of circadian rhythms on sleep, physiology, cognition and health
Mechanisms controlling circadian rhythms, centrally and peripherally
Impact of circadian rhythm disruptions (including night shift work, jet lag and social jet lag) on sleep, physiology, cognition and health
Behavioral and pharmacological interventions aimed at reducing adverse effects of circadian-related sleep disruption
Assessment of technologies and biomarkers for measuring sleep and/or circadian rhythms
Epigenetic markers of sleep or circadian disruption.